Dendritic cells (DCs) refer to rare kind of leukocytes. They have prompted their recent application to therapeutic cancer vaccinations as they are uniquely effective in their ability to present antigens to T cells. Isolated DCs loaded with tumor antigen ex vivo and administered as a cellular vaccine are found to induce protective and therapeutic anti-tumor immunity in experimental animals.
This report aims to provide a comprehensive presentation of the global market for Dendritic Cell Cancer Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Dendritic Cell Cancer Vaccines. This report contains market size and forecasts of Dendritic Cell Cancer Vaccines in global, including the following market information:
Global Dendritic Cell Cancer Vaccines Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Dendritic Cell Cancer Vaccines market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Increase in prevalence of cancer, improvement of technology such as drug innovations regarding cancer, upsurge in awareness about cancer and their available therapies in the market, and increase in health care expenditure drive the market.
We surveyed the Dendritic Cell Cancer Vaccines companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Dendritic Cell Cancer Vaccines Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Dendritic Cell Cancer Vaccines Market Segment Percentages, by Type, 2022 (%)
CreaVax
Sipuleucel-T (Provenge)
Others
Global Dendritic Cell Cancer Vaccines Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Dendritic Cell Cancer Vaccines Market Segment Percentages, by Application, 2022 (%)
Pediatrics
Adults
Global Dendritic Cell Cancer Vaccines Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Dendritic Cell Cancer Vaccines Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Dendritic Cell Cancer Vaccines revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Dendritic Cell Cancer Vaccines revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
3M Company
Activarti
Argos Therapeutics
Batavia Bioservices
Bellicum Pharmaceuticals
Creagene
DanDrit Biotech
DCPrime
Sanpower Corporation
Elios Therapeutics
ImmunoCellular Therapeutics
Immunicum
Kiromic
Medigene
Merck
Northwest Biotherapeutics
Glaxo Smith Kline
Tellaorporation
Vaxil BioTherapeutics
Outline of Major Chapters:
Chapter 1: Introduces the definition of Dendritic Cell Cancer Vaccines, market overview.
Chapter 2: Global Dendritic Cell Cancer Vaccines market size in revenue.
Chapter 3: Detailed analysis of Dendritic Cell Cancer Vaccines company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Dendritic Cell Cancer Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Dendritic Cell Cancer Vaccines Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Dendritic Cell Cancer Vaccines Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Dendritic Cell Cancer Vaccines Overall Market Size
2.1 Global Dendritic Cell Cancer Vaccines Market Size: 2022 VS 2029
2.2 Global Dendritic Cell Cancer Vaccines Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Dendritic Cell Cancer Vaccines Players in Global Market
3.2 Top Global Dendritic Cell Cancer Vaccines Companies Ranked by Revenue
3.3 Global Dendritic Cell Cancer Vaccines Revenue by Companies
3.4 Top 3 and Top 5 Dendritic Cell Cancer Vaccines Companies in Global Market, by Revenue in 2022
3.5 Global Companies Dendritic Cell Cancer Vaccines Product Type
3.6 Tier 1, Tier 2 and Tier 3 Dendritic Cell Cancer Vaccines Players in Global Market
3.6.1 List of Global Tier 1 Dendritic Cell Cancer Vaccines Companies
3.6.2 List of Global Tier 2 and Tier 3 Dendritic Cell Cancer Vaccines Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Dendritic Cell Cancer Vaccines Market Size Markets, 2022 & 2029
4.1.2 CreaVax
4.1.3 Sipuleucel-T (Provenge)
4.1.4 Others
4.2 By Type - Global Dendritic Cell Cancer Vaccines Revenue & Forecasts
4.2.1 By Type - Global Dendritic Cell Cancer Vaccines Revenue, 2018-2023
4.2.2 By Type - Global Dendritic Cell Cancer Vaccines Revenue, 2024-2029
4.2.3 By Type - Global Dendritic Cell Cancer Vaccines Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Dendritic Cell Cancer Vaccines Market Size, 2022 & 2029
5.1.2 Pediatrics
5.1.3 Adults
5.2 By Application - Global Dendritic Cell Cancer Vaccines Revenue & Forecasts
5.2.1 By Application - Global Dendritic Cell Cancer Vaccines Revenue, 2018-2023
5.2.2 By Application - Global Dendritic Cell Cancer Vaccines Revenue, 2024-2029
5.2.3 By Application - Global Dendritic Cell Cancer Vaccines Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Dendritic Cell Cancer Vaccines Market Size, 2022 & 2029
6.2 By Region - Global Dendritic Cell Cancer Vaccines Revenue & Forecasts
6.2.1 By Region - Global Dendritic Cell Cancer Vaccines Revenue, 2018-2023
6.2.2 By Region - Global Dendritic Cell Cancer Vaccines Revenue, 2024-2029
6.2.3 By Region - Global Dendritic Cell Cancer Vaccines Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Dendritic Cell Cancer Vaccines Revenue, 2018-2029
6.3.2 US Dendritic Cell Cancer Vaccines Market Size, 2018-2029
6.3.3 Canada Dendritic Cell Cancer Vaccines Market Size, 2018-2029
6.3.4 Mexico Dendritic Cell Cancer Vaccines Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Dendritic Cell Cancer Vaccines Revenue, 2018-2029
6.4.2 Germany Dendritic Cell Cancer Vaccines Market Size, 2018-2029
6.4.3 France Dendritic Cell Cancer Vaccines Market Size, 2018-2029
6.4.4 U.K. Dendritic Cell Cancer Vaccines Market Size, 2018-2029
6.4.5 Italy Dendritic Cell Cancer Vaccines Market Size, 2018-2029
6.4.6 Russia Dendritic Cell Cancer Vaccines Market Size, 2018-2029
6.4.7 Nordic Countries Dendritic Cell Cancer Vaccines Market Size, 2018-2029
6.4.8 Benelux Dendritic Cell Cancer Vaccines Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Dendritic Cell Cancer Vaccines Revenue, 2018-2029
6.5.2 China Dendritic Cell Cancer Vaccines Market Size, 2018-2029
6.5.3 Japan Dendritic Cell Cancer Vaccines Market Size, 2018-2029
6.5.4 South Korea Dendritic Cell Cancer Vaccines Market Size, 2018-2029
6.5.5 Southeast Asia Dendritic Cell Cancer Vaccines Market Size, 2018-2029
6.5.6 India Dendritic Cell Cancer Vaccines Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Dendritic Cell Cancer Vaccines Revenue, 2018-2029
6.6.2 Brazil Dendritic Cell Cancer Vaccines Market Size, 2018-2029
6.6.3 Argentina Dendritic Cell Cancer Vaccines Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Dendritic Cell Cancer Vaccines Revenue, 2018-2029
6.7.2 Turkey Dendritic Cell Cancer Vaccines Market Size, 2018-2029
6.7.3 Israel Dendritic Cell Cancer Vaccines Market Size, 2018-2029
6.7.4 Saudi Arabia Dendritic Cell Cancer Vaccines Market Size, 2018-2029
6.7.5 UAE Dendritic Cell Cancer Vaccines Market Size, 2018-2029
7 Dendritic Cell Cancer Vaccines Companies Profiles
7.1 3M Company
7.1.1 3M Company Company Summary
7.1.2 3M Company Business Overview
7.1.3 3M Company Dendritic Cell Cancer Vaccines Major Product Offerings
7.1.4 3M Company Dendritic Cell Cancer Vaccines Revenue in Global Market (2018-2023)
7.1.5 3M Company Key News & Latest Developments
7.2 Activarti
7.2.1 Activarti Company Summary
7.2.2 Activarti Business Overview
7.2.3 Activarti Dendritic Cell Cancer Vaccines Major Product Offerings
7.2.4 Activarti Dendritic Cell Cancer Vaccines Revenue in Global Market (2018-2023)
7.2.5 Activarti Key News & Latest Developments
7.3 Argos Therapeutics
7.3.1 Argos Therapeutics Company Summary
7.3.2 Argos Therapeutics Business Overview
7.3.3 Argos Therapeutics Dendritic Cell Cancer Vaccines Major Product Offerings
7.3.4 Argos Therapeutics Dendritic Cell Cancer Vaccines Revenue in Global Market (2018-2023)
7.3.5 Argos Therapeutics Key News & Latest Developments
7.4 Batavia Bioservices
7.4.1 Batavia Bioservices Company Summary
7.4.2 Batavia Bioservices Business Overview
7.4.3 Batavia Bioservices Dendritic Cell Cancer Vaccines Major Product Offerings
7.4.4 Batavia Bioservices Dendritic Cell Cancer Vaccines Revenue in Global Market (2018-2023)
7.4.5 Batavia Bioservices Key News & Latest Developments
7.5 Bellicum Pharmaceuticals
7.5.1 Bellicum Pharmaceuticals Company Summary
7.5.2 Bellicum Pharmaceuticals Business Overview
7.5.3 Bellicum Pharmaceuticals Dendritic Cell Cancer Vaccines Major Product Offerings
7.5.4 Bellicum Pharmaceuticals Dendritic Cell Cancer Vaccines Revenue in Global Market (2018-2023)
7.5.5 Bellicum Pharmaceuticals Key News & Latest Developments
7.6 Creagene
7.6.1 Creagene Company Summary
7.6.2 Creagene Business Overview
7.6.3 Creagene Dendritic Cell Cancer Vaccines Major Product Offerings
7.6.4 Creagene Dendritic Cell Cancer Vaccines Revenue in Global Market (2018-2023)
7.6.5 Creagene Key News & Latest Developments
7.7 DanDrit Biotech
7.7.1 DanDrit Biotech Company Summary
7.7.2 DanDrit Biotech Business Overview
7.7.3 DanDrit Biotech Dendritic Cell Cancer Vaccines Major Product Offerings
7.7.4 DanDrit Biotech Dendritic Cell Cancer Vaccines Revenue in Global Market (2018-2023)
7.7.5 DanDrit Biotech Key News & Latest Developments
7.8 DCPrime
7.8.1 DCPrime Company Summary
7.8.2 DCPrime Business Overview
7.8.3 DCPrime Dendritic Cell Cancer Vaccines Major Product Offerings
7.8.4 DCPrime Dendritic Cell Cancer Vaccines Revenue in Global Market (2018-2023)
7.8.5 DCPrime Key News & Latest Developments
7.9 Sanpower Corporation
7.9.1 Sanpower Corporation Company Summary
7.9.2 Sanpower Corporation Business Overview
7.9.3 Sanpower Corporation Dendritic Cell Cancer Vaccines Major Product Offerings
7.9.4 Sanpower Corporation Dendritic Cell Cancer Vaccines Revenue in Global Market (2018-2023)
7.9.5 Sanpower Corporation Key News & Latest Developments
7.10 Elios Therapeutics
7.10.1 Elios Therapeutics Company Summary
7.10.2 Elios Therapeutics Business Overview
7.10.3 Elios Therapeutics Dendritic Cell Cancer Vaccines Major Product Offerings
7.10.4 Elios Therapeutics Dendritic Cell Cancer Vaccines Revenue in Global Market (2018-2023)
7.10.5 Elios Therapeutics Key News & Latest Developments
7.11 ImmunoCellular Therapeutics
7.11.1 ImmunoCellular Therapeutics Company Summary
7.11.2 ImmunoCellular Therapeutics Business Overview
7.11.3 ImmunoCellular Therapeutics Dendritic Cell Cancer Vaccines Major Product Offerings
7.11.4 ImmunoCellular Therapeutics Dendritic Cell Cancer Vaccines Revenue in Global Market (2018-2023)
7.11.5 ImmunoCellular Therapeutics Key News & Latest Developments
7.12 Immunicum
7.12.1 Immunicum Company Summary
7.12.2 Immunicum Business Overview
7.12.3 Immunicum Dendritic Cell Cancer Vaccines Major Product Offerings
7.12.4 Immunicum Dendritic Cell Cancer Vaccines Revenue in Global Market (2018-2023)
7.12.5 Immunicum Key News & Latest Developments
7.13 Kiromic
7.13.1 Kiromic Company Summary
7.13.2 Kiromic Business Overview
7.13.3 Kiromic Dendritic Cell Cancer Vaccines Major Product Offerings
7.13.4 Kiromic Dendritic Cell Cancer Vaccines Revenue in Global Market (2018-2023)
7.13.5 Kiromic Key News & Latest Developments
7.14 Medigene
7.14.1 Medigene Company Summary
7.14.2 Medigene Business Overview
7.14.3 Medigene Dendritic Cell Cancer Vaccines Major Product Offerings
7.14.4 Medigene Dendritic Cell Cancer Vaccines Revenue in Global Market (2018-2023)
7.14.5 Medigene Key News & Latest Developments
7.15 Merck
7.15.1 Merck Company Summary
7.15.2 Merck Business Overview
7.15.3 Merck Dendritic Cell Cancer Vaccines Major Product Offerings
7.15.4 Merck Dendritic Cell Cancer Vaccines Revenue in Global Market (2018-2023)
7.15.5 Merck Key News & Latest Developments
7.16 Northwest Biotherapeutics
7.16.1 Northwest Biotherapeutics Company Summary
7.16.2 Northwest Biotherapeutics Business Overview
7.16.3 Northwest Biotherapeutics Dendritic Cell Cancer Vaccines Major Product Offerings
7.16.4 Northwest Biotherapeutics Dendritic Cell Cancer Vaccines Revenue in Global Market (2018-2023)
7.16.5 Northwest Biotherapeutics Key News & Latest Developments
7.17 Glaxo Smith Kline
7.17.1 Glaxo Smith Kline Company Summary
7.17.2 Glaxo Smith Kline Business Overview
7.17.3 Glaxo Smith Kline Dendritic Cell Cancer Vaccines Major Product Offerings
7.17.4 Glaxo Smith Kline Dendritic Cell Cancer Vaccines Revenue in Global Market (2018-2023)
7.17.5 Glaxo Smith Kline Key News & Latest Developments
7.18 Tellaorporation
7.18.1 Tellaorporation Company Summary
7.18.2 Tellaorporation Business Overview
7.18.3 Tellaorporation Dendritic Cell Cancer Vaccines Major Product Offerings
7.18.4 Tellaorporation Dendritic Cell Cancer Vaccines Revenue in Global Market (2018-2023)
7.18.5 Tellaorporation Key News & Latest Developments
7.19 Vaxil BioTherapeutics
7.19.1 Vaxil BioTherapeutics Company Summary
7.19.2 Vaxil BioTherapeutics Business Overview
7.19.3 Vaxil BioTherapeutics Dendritic Cell Cancer Vaccines Major Product Offerings
7.19.4 Vaxil BioTherapeutics Dendritic Cell Cancer Vaccines Revenue in Global Market (2018-2023)
7.19.5 Vaxil BioTherapeutics Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Dendritic Cell Cancer Vaccines Market Opportunities & Trends in Global Market
Table 2. Dendritic Cell Cancer Vaccines Market Drivers in Global Market
Table 3. Dendritic Cell Cancer Vaccines Market Restraints in Global Market
Table 4. Key Players of Dendritic Cell Cancer Vaccines in Global Market
Table 5. Top Dendritic Cell Cancer Vaccines Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Dendritic Cell Cancer Vaccines Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Dendritic Cell Cancer Vaccines Revenue Share by Companies, 2018-2023
Table 8. Global Companies Dendritic Cell Cancer Vaccines Product Type
Table 9. List of Global Tier 1 Dendritic Cell Cancer Vaccines Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Dendritic Cell Cancer Vaccines Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Dendritic Cell Cancer Vaccines Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Dendritic Cell Cancer Vaccines Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Dendritic Cell Cancer Vaccines Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Dendritic Cell Cancer Vaccines Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Dendritic Cell Cancer Vaccines Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Dendritic Cell Cancer Vaccines Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Dendritic Cell Cancer Vaccines Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Dendritic Cell Cancer Vaccines Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Dendritic Cell Cancer Vaccines Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Dendritic Cell Cancer Vaccines Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Dendritic Cell Cancer Vaccines Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Dendritic Cell Cancer Vaccines Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Dendritic Cell Cancer Vaccines Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Dendritic Cell Cancer Vaccines Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Dendritic Cell Cancer Vaccines Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Dendritic Cell Cancer Vaccines Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Dendritic Cell Cancer Vaccines Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Dendritic Cell Cancer Vaccines Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Dendritic Cell Cancer Vaccines Revenue, (US$, Mn), 2024-2029
Table 30. 3M Company Company Summary
Table 31. 3M Company Dendritic Cell Cancer Vaccines Product Offerings
Table 32. 3M Company Dendritic Cell Cancer Vaccines Revenue (US$, Mn) & (2018-2023)
Table 33. 3M Company Key News & Latest Developments
Table 34. Activarti Company Summary
Table 35. Activarti Dendritic Cell Cancer Vaccines Product Offerings
Table 36. Activarti Dendritic Cell Cancer Vaccines Revenue (US$, Mn) & (2018-2023)
Table 37. Activarti Key News & Latest Developments
Table 38. Argos Therapeutics Company Summary
Table 39. Argos Therapeutics Dendritic Cell Cancer Vaccines Product Offerings
Table 40. Argos Therapeutics Dendritic Cell Cancer Vaccines Revenue (US$, Mn) & (2018-2023)
Table 41. Argos Therapeutics Key News & Latest Developments
Table 42. Batavia Bioservices Company Summary
Table 43. Batavia Bioservices Dendritic Cell Cancer Vaccines Product Offerings
Table 44. Batavia Bioservices Dendritic Cell Cancer Vaccines Revenue (US$, Mn) & (2018-2023)
Table 45. Batavia Bioservices Key News & Latest Developments
Table 46. Bellicum Pharmaceuticals Company Summary
Table 47. Bellicum Pharmaceuticals Dendritic Cell Cancer Vaccines Product Offerings
Table 48. Bellicum Pharmaceuticals Dendritic Cell Cancer Vaccines Revenue (US$, Mn) & (2018-2023)
Table 49. Bellicum Pharmaceuticals Key News & Latest Developments
Table 50. Creagene Company Summary
Table 51. Creagene Dendritic Cell Cancer Vaccines Product Offerings
Table 52. Creagene Dendritic Cell Cancer Vaccines Revenue (US$, Mn) & (2018-2023)
Table 53. Creagene Key News & Latest Developments
Table 54. DanDrit Biotech Company Summary
Table 55. DanDrit Biotech Dendritic Cell Cancer Vaccines Product Offerings
Table 56. DanDrit Biotech Dendritic Cell Cancer Vaccines Revenue (US$, Mn) & (2018-2023)
Table 57. DanDrit Biotech Key News & Latest Developments
Table 58. DCPrime Company Summary
Table 59. DCPrime Dendritic Cell Cancer Vaccines Product Offerings
Table 60. DCPrime Dendritic Cell Cancer Vaccines Revenue (US$, Mn) & (2018-2023)
Table 61. DCPrime Key News & Latest Developments
Table 62. Sanpower Corporation Company Summary
Table 63. Sanpower Corporation Dendritic Cell Cancer Vaccines Product Offerings
Table 64. Sanpower Corporation Dendritic Cell Cancer Vaccines Revenue (US$, Mn) & (2018-2023)
Table 65. Sanpower Corporation Key News & Latest Developments
Table 66. Elios Therapeutics Company Summary
Table 67. Elios Therapeutics Dendritic Cell Cancer Vaccines Product Offerings
Table 68. Elios Therapeutics Dendritic Cell Cancer Vaccines Revenue (US$, Mn) & (2018-2023)
Table 69. Elios Therapeutics Key News & Latest Developments
Table 70. ImmunoCellular Therapeutics Company Summary
Table 71. ImmunoCellular Therapeutics Dendritic Cell Cancer Vaccines Product Offerings
Table 72. ImmunoCellular Therapeutics Dendritic Cell Cancer Vaccines Revenue (US$, Mn) & (2018-2023)
Table 73. ImmunoCellular Therapeutics Key News & Latest Developments
Table 74. Immunicum Company Summary
Table 75. Immunicum Dendritic Cell Cancer Vaccines Product Offerings
Table 76. Immunicum Dendritic Cell Cancer Vaccines Revenue (US$, Mn) & (2018-2023)
Table 77. Immunicum Key News & Latest Developments
Table 78. Kiromic Company Summary
Table 79. Kiromic Dendritic Cell Cancer Vaccines Product Offerings
Table 80. Kiromic Dendritic Cell Cancer Vaccines Revenue (US$, Mn) & (2018-2023)
Table 81. Kiromic Key News & Latest Developments
Table 82. Medigene Company Summary
Table 83. Medigene Dendritic Cell Cancer Vaccines Product Offerings
Table 84. Medigene Dendritic Cell Cancer Vaccines Revenue (US$, Mn) & (2018-2023)
Table 85. Medigene Key News & Latest Developments
Table 86. Merck Company Summary
Table 87. Merck Dendritic Cell Cancer Vaccines Product Offerings
Table 88. Merck Dendritic Cell Cancer Vaccines Revenue (US$, Mn) & (2018-2023)
Table 89. Merck Key News & Latest Developments
Table 90. Northwest Biotherapeutics Company Summary
Table 91. Northwest Biotherapeutics Dendritic Cell Cancer Vaccines Product Offerings
Table 92. Northwest Biotherapeutics Dendritic Cell Cancer Vaccines Revenue (US$, Mn) & (2018-2023)
Table 93. Northwest Biotherapeutics Key News & Latest Developments
Table 94. Glaxo Smith Kline Company Summary
Table 95. Glaxo Smith Kline Dendritic Cell Cancer Vaccines Product Offerings
Table 96. Glaxo Smith Kline Dendritic Cell Cancer Vaccines Revenue (US$, Mn) & (2018-2023)
Table 97. Glaxo Smith Kline Key News & Latest Developments
Table 98. Tellaorporation Company Summary
Table 99. Tellaorporation Dendritic Cell Cancer Vaccines Product Offerings
Table 100. Tellaorporation Dendritic Cell Cancer Vaccines Revenue (US$, Mn) & (2018-2023)
Table 101. Tellaorporation Key News & Latest Developments
Table 102. Vaxil BioTherapeutics Company Summary
Table 103. Vaxil BioTherapeutics Dendritic Cell Cancer Vaccines Product Offerings
Table 104. Vaxil BioTherapeutics Dendritic Cell Cancer Vaccines Revenue (US$, Mn) & (2018-2023)
Table 105. Vaxil BioTherapeutics Key News & Latest Developments
List of Figures
Figure 1. Dendritic Cell Cancer Vaccines Segment by Type in 2022
Figure 2. Dendritic Cell Cancer Vaccines Segment by Application in 2022
Figure 3. Global Dendritic Cell Cancer Vaccines Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Dendritic Cell Cancer Vaccines Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Dendritic Cell Cancer Vaccines Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Dendritic Cell Cancer Vaccines Revenue in 2022
Figure 8. By Type - Global Dendritic Cell Cancer Vaccines Revenue Market Share, 2018-2029
Figure 9. By Application - Global Dendritic Cell Cancer Vaccines Revenue Market Share, 2018-2029
Figure 10. By Type - Global Dendritic Cell Cancer Vaccines Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Dendritic Cell Cancer Vaccines Revenue Market Share, 2018-2029
Figure 12. By Application - Global Dendritic Cell Cancer Vaccines Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Dendritic Cell Cancer Vaccines Revenue Market Share, 2018-2029
Figure 14. By Region - Global Dendritic Cell Cancer Vaccines Revenue Market Share, 2018-2029
Figure 15. By Country - North America Dendritic Cell Cancer Vaccines Revenue Market Share, 2018-2029
Figure 16. US Dendritic Cell Cancer Vaccines Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Dendritic Cell Cancer Vaccines Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Dendritic Cell Cancer Vaccines Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Dendritic Cell Cancer Vaccines Revenue Market Share, 2018-2029
Figure 20. Germany Dendritic Cell Cancer Vaccines Revenue, (US$, Mn), 2018-2029
Figure 21. France Dendritic Cell Cancer Vaccines Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Dendritic Cell Cancer Vaccines Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Dendritic Cell Cancer Vaccines Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Dendritic Cell Cancer Vaccines Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Dendritic Cell Cancer Vaccines Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Dendritic Cell Cancer Vaccines Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Dendritic Cell Cancer Vaccines Revenue Market Share, 2018-2029
Figure 28. China Dendritic Cell Cancer Vaccines Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Dendritic Cell Cancer Vaccines Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Dendritic Cell Cancer Vaccines Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Dendritic Cell Cancer Vaccines Revenue, (US$, Mn), 2018-2029
Figure 32. India Dendritic Cell Cancer Vaccines Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Dendritic Cell Cancer Vaccines Revenue Market Share, 2018-2029
Figure 34. Brazil Dendritic Cell Cancer Vaccines Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Dendritic Cell Cancer Vaccines Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Dendritic Cell Cancer Vaccines Revenue Market Share, 2018-2029
Figure 37. Turkey Dendritic Cell Cancer Vaccines Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Dendritic Cell Cancer Vaccines Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Dendritic Cell Cancer Vaccines Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Dendritic Cell Cancer Vaccines Revenue, (US$, Mn), 2018-2029
Figure 41. 3M Company Dendritic Cell Cancer Vaccines Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Activarti Dendritic Cell Cancer Vaccines Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Argos Therapeutics Dendritic Cell Cancer Vaccines Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Batavia Bioservices Dendritic Cell Cancer Vaccines Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Bellicum Pharmaceuticals Dendritic Cell Cancer Vaccines Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Creagene Dendritic Cell Cancer Vaccines Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. DanDrit Biotech Dendritic Cell Cancer Vaccines Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. DCPrime Dendritic Cell Cancer Vaccines Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Sanpower Corporation Dendritic Cell Cancer Vaccines Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Elios Therapeutics Dendritic Cell Cancer Vaccines Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. ImmunoCellular Therapeutics Dendritic Cell Cancer Vaccines Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Immunicum Dendritic Cell Cancer Vaccines Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. Kiromic Dendritic Cell Cancer Vaccines Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 54. Medigene Dendritic Cell Cancer Vaccines Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 55. Merck Dendritic Cell Cancer Vaccines Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 56. Northwest Biotherapeutics Dendritic Cell Cancer Vaccines Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 57. Glaxo Smith Kline Dendritic Cell Cancer Vaccines Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 58. Tellaorporation Dendritic Cell Cancer Vaccines Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 59. Vaxil BioTherapeutics Dendritic Cell Cancer Vaccines Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
